Kagan Cocozza Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$387K Sell
1,462
-120
-8% -$31.7K 0.24% 54
2026
Q2
$402K Sell
1,582
-3
-0.2% -$699 0.25% 51
2026
Q1
$387K Sell
1,585
-186
-11% -$43.3K 0.27% 52
2025
Q4
$366K Buy
1,771
+40
+2% +$7.91K 0.26% 50
2025
Q3
$321K Sell
1,731
-32
-2% -$5.48K 0.24% 53
2025
Q2
$269K Hold
1,763
– – 0.21% 58
2025
Q1
$292K Buy
1,763
+5
+0.3% +$782 0.24% 56
2024
Q4
$254K Buy
+1,758
New +$272K 0.21% 60

Other funds holding JNJ

Kagan Cocozza Asset Management's JNJ Position: Q3 2026 in Review

Kagan Cocozza Asset Management reduced its Johnson & Johnson (JNJ) stake by 7.6% in Q3 2026, selling an estimated $31.7K and leaving 1,462 shares worth $387K. The position accounts for 0.24% of the portfolio, ranked #54.

Kagan Cocozza Asset Management first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. The position peaked at $402K in Q2 2026. 2,102 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Kagan Cocozza Asset Management held 1,462 shares of Johnson & Johnson worth $387K as of Q3 2026.
  • Kagan Cocozza Asset Management sold 120 Johnson & Johnson shares in Q3 2026, an estimated $31.7K.
  • Johnson & Johnson made up 0.24% of Kagan Cocozza Asset Management's portfolio in Q3 2026, its #54 holding.
  • Kagan Cocozza Asset Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • Kagan Cocozza Asset Management's Johnson & Johnson position peaked at $402K in Q2 2026.
  • 2,102 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Kagan Cocozza Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.